Selected article for: "antibiotic treatment and supportive treatment"
Author: Ying Huang; Rui Yang; Ying Xu; Ping Gong
Title: Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China
  • Document date: 2020_2_29
    • ID: 9hh17k86_38
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.27.20029009 doi: medRxiv preprint which was consistent with our study. Antibiotic treatment was used to prevent secondary infections since these patients were critically ill. Antiviral regimes were also used in most patients which we hoped may have roles but still need more data. However, there were no specific remedies for SARS-CoV-2 yet.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.27.20029009 doi: medRxiv preprint which was consistent with our study. Antibiotic treatment was used to prevent secondary infections since these patients were critically ill. Antiviral regimes were also used in most patients which we hoped may have roles but still need more data. However, there were no specific remedies for SARS-CoV-2 yet 11, 12 . Therefore, most patients were treated with supportive treatment and intensive care. Unfortunately, due to restrictions of hospital's conditions and the heavy burden of COVID-19 in Wuhan City, neither were we able to provide patients in need with advanced life support systems like Extracorporeal Membrane Oxygenation (ECMO), nor were able to transport all serious patients to superior hospital for better medical treatments in time. The median survival time of the patients in our study was only 2 weeks approximately, which was shorter compared to previous reports 13 will decrease as the clinical capacity improves.

    Search related documents:
    Co phrase search for related documents
    • patient provide and study patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
    • patient transport and study patient: 1, 2, 3, 4, 5, 6
    • patient transport and support system: 1
    • patient transport and survival time: 1
    • previous report and study patient: 1
    • previous report and supportive treatment: 1
    • previous report and survival time: 1, 2, 3
    • secondary infection and study patient: 1, 2, 3, 4, 5, 6
    • secondary infection and superior hospital: 1
    • secondary infection and support system: 1
    • secondary infection and supportive treatment: 1, 2, 3, 4, 5, 6, 7
    • secondary infection and survival time: 1, 2
    • specific remedy and supportive treatment: 1, 2
    • study patient and support system: 1, 2, 3
    • study patient and supportive treatment: 1, 2, 3
    • study patient and survival time: 1, 2, 3, 4, 5, 6
    • superior hospital and survival time: 1
    • support system and survival time: 1
    • supportive treatment and survival time: 1